Gonadal function after combination chemotherapy for Hodgkin's disease in childhood.
AffiliationChristie Hospital, Manchester
MetadataShow full item record
AbstractThe effect of quadruple chemotherapy (mustine, vincristine, procarbazine, and prednisolone) on gonadal function was investigated in 15 males and 2 females treated for Hodgkin's disease during childhood. The 2 females have regular menstrual cycles with evidence of ovulation in one. Twelve of the males have shown normal progression of pubertal development since completing their treatment. Nine out of 10 late pubertal or adult subjects had small testes but only one developed gynaecomastia. All 4 prepubertal subjects had normal basal and peak gonadotrophin responses to luteinising hormone-releasing hormone. Nine of the 12 subjects studied during puberty or adulthood had either an increased basal serum follicle-stimulating hormone (FSH) level or an exaggerated FSH response to luteinising hormone-releasing hormone. Each of the 6 males who provided semen for analysis was azoospermic after an interval of between 2.4 and 8 (mean 5.3) years after completion of treatment. We conclude that severe testicular damage is common after treatment with mustine, vincristine, procarbazine, and prednisolone in childhood. The germinal epithelium is particularly vulnerable and the resultant azoospermia is likely to be irreversible. The Leydig cells are less susceptible to cytotoxic-induced damage. Pubertal development is normal and there is no indication for androgen replacement therapy.
CitationGonadal function after combination chemotherapy for Hodgkin's disease in childhood. 1982, 57 (4):287-91 Arch Dis Child
JournalArchives of Disease in Childhood
- Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
- Authors: Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM
- Issue date: 1995 Jan
- Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
- Authors: Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N
- Issue date: 1996 Aug
- Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
- Authors: Ortin TT, Shostak CA, Donaldson SS
- Issue date: 1990 Oct
- [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
- Authors: Soriano Guillén L, Muñoz Calvo MT, Pozo Román J, Contra Gómez T, Buño Soto M, Argente Oliver J
- Issue date: 2000 Oct
- Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
- Authors: Dhabhar BN, Malhotra H, Joseph R, Garde S, Bhasin S, Sheth A, Advani SH
- Issue date: 1993 Aug